Artwork

ConteĂșdo fornecido por CREST Bipolar Disorder Network. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por CREST Bipolar Disorder Network ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

Psychedelics & Bipolar Disorder: Psilocybin, Ketamine & Treatment | Dr. Josh Woolley | EP. 18 🍄

1:04:31
 
Compartilhar
 

Manage episode 342741168 series 3400573
ConteĂșdo fornecido por CREST Bipolar Disorder Network. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por CREST Bipolar Disorder Network ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treatment.

Hosted by Dr. Erin Michalak.

Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.

#talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about the talkBD Bipolar Disorder Podcast and upcoming episodes at https://talkBD.live

  continue reading

40 episĂłdios

Artwork
iconCompartilhar
 
Manage episode 342741168 series 3400573
ConteĂșdo fornecido por CREST Bipolar Disorder Network. Todo o conteĂșdo do podcast, incluindo episĂłdios, grĂĄficos e descriçÔes de podcast, Ă© carregado e fornecido diretamente por CREST Bipolar Disorder Network ou por seu parceiro de plataforma de podcast. Se vocĂȘ acredita que alguĂ©m estĂĄ usando seu trabalho protegido por direitos autorais sem sua permissĂŁo, siga o processo descrito aqui https://pt.player.fm/legal.

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treatment.

Hosted by Dr. Erin Michalak.

Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.

#talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about the talkBD Bipolar Disorder Podcast and upcoming episodes at https://talkBD.live

  continue reading

40 episĂłdios

Todos os episĂłdios

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para vocĂȘ curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rĂĄpido de referĂȘncias